NanoCarrier Concludes Joint Research Agreement with Chugai to Develop Next-Generation Anticancer Drugs

February 26, 2015
NanoCarrier announced on February 24 that it has entered into a joint research agreement with Chugai Pharmaceutical. NanoCarrier will issue 389,400 new shares, accounting for 0.96% of its total shares, to Chugai through a third-party allocation. At 1,284 yen per...read more